These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32449777)

  • 1. TinderMIX: Time-dose integrated modelling of toxicogenomics data.
    Serra A; Fratello M; Del Giudice G; Saarimäki LA; Paci M; Federico A; Greco D
    Gigascience; 2020 May; 9(5):. PubMed ID: 32449777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of dynamic topic models to toxicogenomics data.
    Lee M; Liu Z; Huang R; Tong W
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):368. PubMed ID: 27766956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of text and gene--using text mining methods to uncover hidden knowledge in toxicogenomics.
    Lee M; Liu Z; Kelly R; Tong W
    BMC Syst Biol; 2014 Aug; 8():93. PubMed ID: 25115450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
    Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Map and model-moving from observation to prediction in toxicogenomics.
    Schüttler A; Altenburger R; Ammar M; Bader-Blukott M; Jakobs G; Knapp J; Krüger J; Reiche K; Wu GM; Busch W
    Gigascience; 2019 Jun; 8(6):. PubMed ID: 31140561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
    Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
    PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy to detect metabolic changes induced by exposure to chemicals from large sets of condition-specific metabolic models computed with enumeration techniques.
    Fresnais L; Perin O; Riu A; Grall R; Ott A; Fromenty B; Gallardo JC; Stingl M; Frainay C; Jourdan F; Poupin N
    BMC Bioinformatics; 2024 Jul; 25(1):234. PubMed ID: 38992584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTNI: a novel toxicogenomics data analysis tool for identifying the molecular mechanisms underlying the adverse effects of toxic compounds.
    Hendrickx DM; Souza T; Jennen DGJ; Kleinjans JCS
    Arch Toxicol; 2017 Jun; 91(6):2343-2352. PubMed ID: 28032149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
    Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical application of toxicogenomics for profiling toxicant-induced biological perturbations.
    Kiyosawa N; Manabe S; Yamoto T; Sanbuissho A
    Int J Mol Sci; 2010 Sep; 11(9):3397-412. PubMed ID: 20957103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.
    Römer M; Eichner J; Metzger U; Templin MF; Plummer S; Ellinger-Ziegelbauer H; Zell A
    PLoS One; 2014; 9(5):e97640. PubMed ID: 24830643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment.
    Farmahin R; Williams A; Kuo B; Chepelev NL; Thomas RS; Barton-Maclaren TS; Curran IH; Nong A; Wade MG; Yauk CL
    Arch Toxicol; 2017 May; 91(5):2045-2065. PubMed ID: 27928627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in toxicogenomics: understanding and predicting compound-induced toxicity from gene expression data.
    Alexander-Dann B; Pruteanu LL; Oerton E; Sharma N; Berindan-Neagoe I; Módos D; Bender A
    Mol Omics; 2018 Aug; 14(4):218-236. PubMed ID: 29917034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ENM Dynamic Dose-Dependent MOA in Lung with Respect to Immune Cells Infiltration.
    Serra A; Del Giudice G; Kinaret PAS; Saarimäki LA; Poulsen SS; Fortino V; Halappanavar S; Vogel U; Greco D
    Nanomaterials (Basel); 2022 Jun; 12(12):. PubMed ID: 35745370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity mechanisms identification via gene set enrichment analysis of time-series toxicogenomics data: impact of time and concentration.
    Gao C; Weisman D; Lan J; Gou N; Gu AZ
    Environ Sci Technol; 2015 Apr; 49(7):4618-26. PubMed ID: 25785649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive Toxicogenomics: Gene set discovery, clustering and analysis in Toxygates.
    Nyström-Persson J; Natsume-Kitatani Y; Igarashi Y; Satoh D; Mizuguchi K
    Sci Rep; 2017 May; 7(1):1390. PubMed ID: 28469246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.
    Chepelev NL; Moffat ID; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Malik AI; Halappanavar S; Williams A; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):44-52. PubMed ID: 25605027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.
    Eichner J; Wrzodek C; Römer M; Ellinger-Ziegelbauer H; Zell A
    PLoS One; 2014; 9(5):e97678. PubMed ID: 24828355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.
    Herwig R; Gmuender H; Corvi R; Bloch KM; Brandenburg A; Castell J; Ceelen L; Chesne C; Doktorova TY; Jennen D; Jennings P; Limonciel A; Lock EA; McMorrow T; Phrakonkham P; Radford R; Slattery C; Stierum R; Vilardell M; Wittenberger T; Yildirimman R; Ryan M; Rogiers V; Kleinjans J
    Arch Toxicol; 2016 Sep; 90(9):2215-2229. PubMed ID: 26525393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.